ch as KEYTRUDA. We believe this gene signature has the potential to become the basis for a universally available assay that serves as the gold standard for informing treatment with immuno-oncology therapies, said Brad Gray, President and Chief Executive Officer of NanoString Technologies. This c
Date: Feb 29, 2016
Category: Business
Source: Google
Merck (MRK), NanoSttring (NSTG) Enter Collaboration for KEYTRUDA Assay ...
We are excited to work with Merck to help direct treatment with KEYTRUDA, said Brad Gray, president and chief executive officer of NanoString Technologies. New approaches in immuno-oncology, like KEYTRUDA, have the potential to transform cancer care across many different tumor types. With our nCo
Date: May 28, 2015
Category: Health
Source: Google
Merck & Co., Inc. Extends Reach Into Immunotherapy Drugs Market; Joins ...
aid NanoString Technologies in the area of immuno-oncology biomarkers. Brad Gray, president and chief executive officer at NanoString, pointed out the benefits accruing from the partnership, in the companys press release: We are excited to work with Merck to help direct treatment with KEYTRUDA. New
Date: May 28, 2015
Category: Health
Source: Google
“Transformers: Dark of the Moon” soars past $1 billion mark
r the extraordinary work of Michael Bay and his film-making team, executive producer Steven Spielberg, and everyone at Paramount around the globe who played a part in helping make this latest Transformers one of the 10 highest grossing films worldwide of all time, Paramount chairman-CEO Brad Gray sai